Author

Tim Maiwald

Primary ORCID profile (0000-0002-4525-9556 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Tim MaiwaldiD1 paper · University of Freiburg

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Aimin Yan· 1 shared Axel SchambachiD· 1 shared Cecilia N. Barese· 1 shared Chris MasoniD· 1 shared Christine Oborski· 1 shared Christopher M. Treleaven· 1 shared Claudia FioriniiD· 1 shared Cristina Baricordi· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Aimin Yan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestations

John K. Yoon, Jeffrey W. Schindler, Mariana Loperfido, Cristina Baricordi, Mark P. DeAndrade, Mary E. Jacobs, Christopher M. Treleaven, Robert N. Plasschaert, Aimin Yan, Cecilia N. Barese, Yildirim Dogan, Vicky Ping Chen, Claudia Fiorini, Fritz Hull, Luigi Barbarossa, , Niek Peter van Til

This study shows lentiviral HSPC gene therapy can reverse Pompe disease symptoms in mice by correcting muscle and neurological issues.

Molecular Therapy · Sep 17, 2024Peer-reviewedNeuroscience